SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

COFFINDAFFER THADDEUS

(Last)

(First)

(Middle)

3905 ANNAPOLIS LANE N.

(Street)

PLYMOUTH

55447

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ATS MEDICAL INC [ ATSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President of Sales

3. Date of Earliest Transaction (Month/Day/Year)
01/11/2010

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/11/2010		M		4,000	A	$0.00	119,151.667⁽¹⁾⁽²⁾	D
Common Stock	01/11/2010		S⁽³⁾		40⁽³⁾	D	$3.253	119,111.667	D
Common Stock	01/11/2010		S⁽³⁾		950⁽³⁾	D	$3.2562	118,161.667	D
Common Stock	01/11/2010		S⁽³⁾		350⁽³⁾	D	$3.276	117,811.667⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$3.36							⁽⁴⁾	08/06/2013	Common Stock	100,000		100,000	D
Stock Option (Right to Buy)	$3.8							⁽⁴⁾	10/28/2013	Common Stock	5,000		5,000	D
Stock Option (Right to Buy)	$3.8							⁽⁴⁾	12/19/2013	Common Stock	20,000		20,000	D
Restricted Stock Units	⁽⁵⁾	01/11/2010		M			4,000	01/10/2007⁽⁶⁾	01/10/2011⁽⁷⁾	Common Stock	8,000	$0.00	4,000	D
Restricted Stock Units	⁽⁵⁾							03/15/2008⁽⁶⁾	03/15/2012⁽⁷⁾	Common Stock	45,000		45,000	D
Restricted Stock Units	⁽⁵⁾							03/15/2008⁽⁸⁾	03/15/2012⁽⁷⁾	Common Stock	12,066		12,066	D
Restricted Stock Units	⁽⁵⁾							03/15/2009⁽⁸⁾	03/15/2013⁽⁷⁾	Common Stock	70,103		70,103	D
Restricted Stock Units	⁽⁵⁾							07/30/2009⁽⁹⁾	07/30/2013⁽⁹⁾	Common Stock	4,000		40,000	D
Restricted Stock Unit	⁽⁵⁾							03/15/2010⁽⁶⁾	03/15/2014⁽⁷⁾	Common Stock	60,665		66,065	D

Explanation of Responses:

1. Includes shares held in Employee Stock Purchase Plan as of a plan date of April 30, 2009.

2. Reflects an increase of 5,250 shares which have not been included on three Forms 4 filed between January 2009 and this filing. A Form 4 relating to vesting on January 12, 2009 of restricted stock units has been filed concurently with this filing.

3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2009.

4. Fully vested.

5. 1 unit for 1 share of Common Stock

6. Vests in 20% annual cumulative installments beginning the date shown.

7. Represents last vesting date.

8. Vests in 25% annual cumulative installments beginning the date shown.

9. Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.

Remarks:

	/s/ Deborah K. Chapman, Attorney in Fact for Thaddeus Coffindaffer	01/12/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.